Sanofi calls it quits on mR­NA Covid-19 shots, scrap­ping vac­cine from $3.2B Trans­late Bio buy­out

Sanofi is throw­ing in the tow­el on mR­NA-based Covid-19 vac­cines.

The French drug­mak­er will halt de­vel­op­ment on its un­mod­i­fied mR­NA Covid-19 shot de­spite what it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER